日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Durable response to FOLFOX plus serplulimab in AFP-producing gastric adenocarcinoma with liver metastases: a case report and literature review

FOLFOX联合serplulimab治疗伴肝转移的AFP分泌型胃腺癌获得持久疗效：病例报告及文献综述

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2026.1795732
Jin, Yuqi; Fu, Linglin; Zhao, Yuhan; Tong, Ziyan; Tan, Yinuo
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

ROS-Responsive Hydrogel for Localized Delivery of Nampt and Stat3 Inhibitors Exhibits Synergistic Antitumor Effects in Colorectal Cancer Through Ferroptosis Induction and Immune Microenvironment Remodeling.

ROS响应型水凝胶可局部递送Nampt和Stat3抑制剂，通过诱导铁死亡和重塑免疫微环境，在结直肠癌中表现出协同抗肿瘤作用

期刊:Advanced Science
影响因子:14.1
doi:10.1002/advs.202506599
Ye Chenyang, Mi Mi, Shi Saimeng, Qi Lina, Weng Shanshan, Wang Lu, Lu Yier, Chen Chao, Tan Yinuo, Yang Mengyuan, Guo Cheng, Bai Rui, Fang Xuefeng, Wang Ji, Yuan Ying
肿瘤
铁死亡
发表日期：2025
文献求助 收藏

Case Report: When dual immune checkpoint blockade strikes back: cadonilimab-induced hypersensitivity in solid tumors - a case series and review

病例报告：双重免疫检查点阻断疗法的反作用：卡多尼利单抗诱导的实体瘤超敏反应——病例系列及综述

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2025.1643279
Song, Ping; Jin, Yuqi; Fu, Linglin; Yang, Fengming; Tan, Yinuo
免疫/内分泌
发表日期：2025
文献求助 收藏

A case of camrelizumab-induced anaphylaxis and successful rechallenge: a case report and literature review

卡瑞利珠单抗诱发过敏反应及再次用药成功病例报告及文献综述

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2025.1537205
Song, Ping; Jin, Yuqi; Dai, Lifang; Fang, Lijun; Tan, Yinuo
发表日期：2025
文献求助 收藏

Donafenib intolerance in hepatocellular carcinoma: severe hand-foot skin reaction and successful switch to lenvatinib - a case report and literature review

多那非尼不耐受肝细胞癌：严重手足皮肤反应及成功换用乐伐替尼——病例报告及文献综述

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2025.1728098
Chen, Ying; Fu, Linglin; Song, Ping; Tan, Yinuo; Jin, Yuqi
细胞生物学
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Phase 1a study of ESG401, a Trop2 antibody-drug conjugate, in patients with locally advanced/metastatic solid tumors

ESG401（一种Trop2抗体药物偶联物）治疗局部晚期/转移性实体瘤患者的1a期研究

期刊:Cell Reports Medicine
影响因子:10.6
doi:10.1016/j.xcrm.2024.101707
Wang, Jiani; Tong, Zhongsheng; Tan, Yinuo; Shi, Yehui; Wu, Yun; Zhou, Qing; Xing, Xiaoyan; Chen, Xiaomei; Qiu, Fuming; Ma, Fei
发表日期：2024
文献求助 收藏

Radiation Therapy Changed the Second Malignancy Pattern in Rectal Cancer Survivors

放射治疗改变了直肠癌幸存者的第二原发恶性肿瘤模式

期刊:Medicina-Lithuania
影响因子:2.4
doi:10.3390/medicina59081463
Ye, Xiaoxian; Tan, Yinuo; Ma, Ruishuang; Lou, Pengrong; Yuan, Ying
肿瘤
肠癌
肿瘤免疫
发表日期：2023
文献求助 收藏

Erratum to A truncated protein product of the germline variant of the DUOX2 gene leads to adenomatous polyposis

勘误：DUOX2基因种系变异体的截短蛋白产物导致腺瘤性息肉病

期刊:Cancer Biology & Medicine
影响因子:8.4
doi:10.20892/j.issn.2095-3941.2021.1213
Yang, Mengyuan; Zhao, Yingxin; Ding, Yuwei; Wang, Juan; Tan, Yinuo; Xu, Dong; Yuan, Ying
DUOX2
发表日期：2022
文献求助 收藏

Comprehensive Analysis of the Brain-Expressed X-Link Protein Family in Glioblastoma Multiforme

对多形性胶质母细胞瘤中脑表达的X染色体连锁蛋白家族的全面分析

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2022.911942
Aisa, Adilai; Tan, Yinuo; Li, Xinyu; Zhang, Ding; Shi, Yun; Yuan, Ying
细胞生物学
神经科学
发表日期：2022
文献求助 收藏

REV1: A novel biomarker and potential therapeutic target for various cancers

REV1：一种新型生物标志物和多种癌症的潜在治疗靶点

期刊:Frontiers in Genetics
影响因子:2.8
doi:10.3389/fgene.2022.997970
Zhu, Ning; Zhao, Yingxin; Mi, Mi; Lu, Yier; Tan, Yinuo; Fang, Xuefeng; Weng, Shanshan; Yuan, Ying
肿瘤
REV1
肿瘤免疫
发表日期：2022
文献求助 收藏